AHR and cancer: While the molecular signal that results in these apparently contradictory results is still unknown, it has been postulated that agonists such as TCDD, 3,3′-diindolylmethane, or Omeprazole [217] induce differential cofactor recruitment by the AHR then those recruited by endogenous ligands in cancer [107,218].